Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases
BACKGROUND Specific cutaneous involvement in patients with multiple myeloma (MM) is very uncommon. It usually occurs in late stages of MM as a reflection of increased tumor cell burden. We studied 8 patients with cutaneous involvement of MM without underlying bony lesions and reviewed the literature...
Gespeichert in:
Veröffentlicht in: | Archives of dermatology (1960) 2003-04, Vol.139 (4), p.475-486 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 486 |
---|---|
container_issue | 4 |
container_start_page | 475 |
container_title | Archives of dermatology (1960) |
container_volume | 139 |
creator | Requena, Luis Kutzner, Heinz Palmedo, Gabriele Calonje, Eduardo Requena, Celia Pérez, Gemma Pastor, María Antonia Sangueza, Omar P |
description | BACKGROUND Specific cutaneous involvement in patients with multiple myeloma (MM) is very uncommon. It usually occurs in late stages of MM as a reflection of increased tumor cell burden. We studied 8 patients with cutaneous involvement of MM without underlying bony lesions and reviewed the literature on this rare dermatologic manifestation. DESIGN We were particularly interested in the clinical course of patients with MM and cutaneous metastases, including survival once metastases were detected and the possible influence of various forms of therapy. Our goal was also to identify the immunoglobulin and the light-chain type in these cases, with emphasis on any possible association between a particular immunoglobulin class and cutaneous involvement, as well as the histopathologic, immunohistochemical, and cytogenetic features of the neoplastic plasma cells involving the skin. SETTING University department of dermatology, university hospital, and private practice. PATIENTS Medical records and biopsy specimens from 8 patients with MM and specific cutaneous lesions were reviewed. RESULTS
Cutaneous lesions consisted of multiple erythematous or violaceous nodules or plaques with a wide anatomical distribution. Histopathologically, 2 different patterns were identified: nodular and diffuse interstitial. Neoplastic plasma cells showed atypical features, and in 1 case they displayed a spindle shape, giving a sarcomatoid appearance to the lesion. Immunohistochemical studies demonstrated that neoplastic plasma cells were strongly positive for CD79a, CD138, and epithelial membrane antigen, and variably positive for VS38c and CD43. In each case the immunoglobulin profile and the light-chain type expression of the neoplastic cells were the same as those identified in the serum of the patients: 5 cases were IgAλ; 2 cases were IgGκ; and 1 case was IgAκ. In cases 2, 3, and 4, polymerase chain reaction investigations revealed monoclonal rearrangement for IgH genes, whereas the investigations for human herpesvirus 8 and Epstein-Barr virus yielded negative results. Fluorescent in situ hybridization investigations in these 3 cases demonstrated that the cutaneous neoplastic plasma cells showed the deletion of the rb-1 (retinoblastoma) gene. Despite aggressive chemotherapy, all 8 patients died a few months after the development of cutaneous involvement.
CONCLUSIONS
In our series, there was a perfect correlation of immunoglobulin and light-chain type between the serum electrophoresis |
doi_str_mv | 10.1001/archderm.139.4.475 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73230836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>479282</ama_id><sourcerecordid>325981511</sourcerecordid><originalsourceid>FETCH-LOGICAL-a325t-72f32f4dc8947568cc5591302a9ab210865e5c5f071fa3465ed9aa7100b9fe83</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhi0EomnhB8ABWUhwaoI_1rHNrVoViNSKAz1wsyZeb-PKH2HtrZR_j1EClTiNRvO8o3fmRegtJStKCP0Ek90NbooryvWqW3VSPEMLKrha8rVgz9GCEMKXWsmfZ-i8lIemYUqxl-iMMkkk0WKB5n6ukFyeC96kxxweXXSpYp_w7Ryq3weHbw8u5Aif8RXug0_e5j3UXQ753ttLvIlxTnnnS81256K3EC4xpAH3h5rvXXLVW_yjzsMB5xEr3ENx5RV6MUIo7vWpXqC7L9d3_bflzfevm_7qZgmcibqUbORs7AardDturawVQlNOGGjYMkrUWjhhxUgkHYF3rRs0gGzP2erRKX6BPh7X7qf8a3almuiLdSEcLzaSM04UXzfw_X_gQ56n1KwZxjlluhloEDtCdsqlTG40-8lHmA6GEvMnEPM3ENMCMZ1pnpvo3WnzvI1ueJKcEmjAhxMApf1unCBZX564TnIphGzcmyMHEf5NO6mZYvw3BW2eMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233129894</pqid></control><display><type>article</type><title>Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Requena, Luis ; Kutzner, Heinz ; Palmedo, Gabriele ; Calonje, Eduardo ; Requena, Celia ; Pérez, Gemma ; Pastor, María Antonia ; Sangueza, Omar P</creator><creatorcontrib>Requena, Luis ; Kutzner, Heinz ; Palmedo, Gabriele ; Calonje, Eduardo ; Requena, Celia ; Pérez, Gemma ; Pastor, María Antonia ; Sangueza, Omar P</creatorcontrib><description>BACKGROUND Specific cutaneous involvement in patients with multiple myeloma (MM) is very uncommon. It usually occurs in late stages of MM as a reflection of increased tumor cell burden. We studied 8 patients with cutaneous involvement of MM without underlying bony lesions and reviewed the literature on this rare dermatologic manifestation. DESIGN We were particularly interested in the clinical course of patients with MM and cutaneous metastases, including survival once metastases were detected and the possible influence of various forms of therapy. Our goal was also to identify the immunoglobulin and the light-chain type in these cases, with emphasis on any possible association between a particular immunoglobulin class and cutaneous involvement, as well as the histopathologic, immunohistochemical, and cytogenetic features of the neoplastic plasma cells involving the skin. SETTING University department of dermatology, university hospital, and private practice. PATIENTS Medical records and biopsy specimens from 8 patients with MM and specific cutaneous lesions were reviewed. RESULTS
Cutaneous lesions consisted of multiple erythematous or violaceous nodules or plaques with a wide anatomical distribution. Histopathologically, 2 different patterns were identified: nodular and diffuse interstitial. Neoplastic plasma cells showed atypical features, and in 1 case they displayed a spindle shape, giving a sarcomatoid appearance to the lesion. Immunohistochemical studies demonstrated that neoplastic plasma cells were strongly positive for CD79a, CD138, and epithelial membrane antigen, and variably positive for VS38c and CD43. In each case the immunoglobulin profile and the light-chain type expression of the neoplastic cells were the same as those identified in the serum of the patients: 5 cases were IgAλ; 2 cases were IgGκ; and 1 case was IgAκ. In cases 2, 3, and 4, polymerase chain reaction investigations revealed monoclonal rearrangement for IgH genes, whereas the investigations for human herpesvirus 8 and Epstein-Barr virus yielded negative results. Fluorescent in situ hybridization investigations in these 3 cases demonstrated that the cutaneous neoplastic plasma cells showed the deletion of the rb-1 (retinoblastoma) gene. Despite aggressive chemotherapy, all 8 patients died a few months after the development of cutaneous involvement.
CONCLUSIONS
In our series, there was a perfect correlation of immunoglobulin and light-chain type between the serum electrophoresis and the cutaneous plasma cells. Patients with MM showed a short survival once cutaneous metastases appeared independently of the therapy. The deletion the rb-1 gene may provide prognostically relevant information to identify a high-risk subset of patients with MM.
Arch Dermatol. 2003;139:475-486--></description><identifier>ISSN: 0003-987X</identifier><identifier>ISSN: 2168-6068</identifier><identifier>EISSN: 1538-3652</identifier><identifier>EISSN: 2168-6084</identifier><identifier>DOI: 10.1001/archderm.139.4.475</identifier><identifier>PMID: 12707095</identifier><identifier>CODEN: ARDEAC</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Aged ; Antigens, CD - analysis ; Biological and medical sciences ; Female ; Gene Deletion ; Genes, Retinoblastoma - genetics ; Hematologic and hematopoietic diseases ; Humans ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulinopathies ; Immunoglobulins - analysis ; Immunohistochemistry ; Immunopathology ; In Situ Hybridization, Fluorescence ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Multiple Myeloma - chemistry ; Multiple Myeloma - genetics ; Multiple Myeloma - pathology ; Plasma Cells - pathology ; Skin - immunology ; Skin - pathology ; Skin Neoplasms - chemistry ; Skin Neoplasms - genetics ; Skin Neoplasms - pathology ; Skin Neoplasms - secondary</subject><ispartof>Archives of dermatology (1960), 2003-04, Vol.139 (4), p.475-486</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright American Medical Association Apr 2003</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamadermatology/articlepdf/10.1001/archderm.139.4.475$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/archderm.139.4.475$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14737557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12707095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Requena, Luis</creatorcontrib><creatorcontrib>Kutzner, Heinz</creatorcontrib><creatorcontrib>Palmedo, Gabriele</creatorcontrib><creatorcontrib>Calonje, Eduardo</creatorcontrib><creatorcontrib>Requena, Celia</creatorcontrib><creatorcontrib>Pérez, Gemma</creatorcontrib><creatorcontrib>Pastor, María Antonia</creatorcontrib><creatorcontrib>Sangueza, Omar P</creatorcontrib><title>Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases</title><title>Archives of dermatology (1960)</title><addtitle>Arch Dermatol</addtitle><description>BACKGROUND Specific cutaneous involvement in patients with multiple myeloma (MM) is very uncommon. It usually occurs in late stages of MM as a reflection of increased tumor cell burden. We studied 8 patients with cutaneous involvement of MM without underlying bony lesions and reviewed the literature on this rare dermatologic manifestation. DESIGN We were particularly interested in the clinical course of patients with MM and cutaneous metastases, including survival once metastases were detected and the possible influence of various forms of therapy. Our goal was also to identify the immunoglobulin and the light-chain type in these cases, with emphasis on any possible association between a particular immunoglobulin class and cutaneous involvement, as well as the histopathologic, immunohistochemical, and cytogenetic features of the neoplastic plasma cells involving the skin. SETTING University department of dermatology, university hospital, and private practice. PATIENTS Medical records and biopsy specimens from 8 patients with MM and specific cutaneous lesions were reviewed. RESULTS
Cutaneous lesions consisted of multiple erythematous or violaceous nodules or plaques with a wide anatomical distribution. Histopathologically, 2 different patterns were identified: nodular and diffuse interstitial. Neoplastic plasma cells showed atypical features, and in 1 case they displayed a spindle shape, giving a sarcomatoid appearance to the lesion. Immunohistochemical studies demonstrated that neoplastic plasma cells were strongly positive for CD79a, CD138, and epithelial membrane antigen, and variably positive for VS38c and CD43. In each case the immunoglobulin profile and the light-chain type expression of the neoplastic cells were the same as those identified in the serum of the patients: 5 cases were IgAλ; 2 cases were IgGκ; and 1 case was IgAκ. In cases 2, 3, and 4, polymerase chain reaction investigations revealed monoclonal rearrangement for IgH genes, whereas the investigations for human herpesvirus 8 and Epstein-Barr virus yielded negative results. Fluorescent in situ hybridization investigations in these 3 cases demonstrated that the cutaneous neoplastic plasma cells showed the deletion of the rb-1 (retinoblastoma) gene. Despite aggressive chemotherapy, all 8 patients died a few months after the development of cutaneous involvement.
CONCLUSIONS
In our series, there was a perfect correlation of immunoglobulin and light-chain type between the serum electrophoresis and the cutaneous plasma cells. Patients with MM showed a short survival once cutaneous metastases appeared independently of the therapy. The deletion the rb-1 gene may provide prognostically relevant information to identify a high-risk subset of patients with MM.
Arch Dermatol. 2003;139:475-486--></description><subject>Aged</subject><subject>Antigens, CD - analysis</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Gene Deletion</subject><subject>Genes, Retinoblastoma - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulinopathies</subject><subject>Immunoglobulins - analysis</subject><subject>Immunohistochemistry</subject><subject>Immunopathology</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - chemistry</subject><subject>Multiple Myeloma - genetics</subject><subject>Multiple Myeloma - pathology</subject><subject>Plasma Cells - pathology</subject><subject>Skin - immunology</subject><subject>Skin - pathology</subject><subject>Skin Neoplasms - chemistry</subject><subject>Skin Neoplasms - genetics</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - secondary</subject><issn>0003-987X</issn><issn>2168-6068</issn><issn>1538-3652</issn><issn>2168-6084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1vEzEQhi0EomnhB8ABWUhwaoI_1rHNrVoViNSKAz1wsyZeb-PKH2HtrZR_j1EClTiNRvO8o3fmRegtJStKCP0Ek90NbooryvWqW3VSPEMLKrha8rVgz9GCEMKXWsmfZ-i8lIemYUqxl-iMMkkk0WKB5n6ukFyeC96kxxweXXSpYp_w7Ryq3weHbw8u5Aif8RXug0_e5j3UXQ753ttLvIlxTnnnS81256K3EC4xpAH3h5rvXXLVW_yjzsMB5xEr3ENx5RV6MUIo7vWpXqC7L9d3_bflzfevm_7qZgmcibqUbORs7AardDturawVQlNOGGjYMkrUWjhhxUgkHYF3rRs0gGzP2erRKX6BPh7X7qf8a3almuiLdSEcLzaSM04UXzfw_X_gQ56n1KwZxjlluhloEDtCdsqlTG40-8lHmA6GEvMnEPM3ENMCMZ1pnpvo3WnzvI1ueJKcEmjAhxMApf1unCBZX564TnIphGzcmyMHEf5NO6mZYvw3BW2eMA</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>Requena, Luis</creator><creator>Kutzner, Heinz</creator><creator>Palmedo, Gabriele</creator><creator>Calonje, Eduardo</creator><creator>Requena, Celia</creator><creator>Pérez, Gemma</creator><creator>Pastor, María Antonia</creator><creator>Sangueza, Omar P</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases</title><author>Requena, Luis ; Kutzner, Heinz ; Palmedo, Gabriele ; Calonje, Eduardo ; Requena, Celia ; Pérez, Gemma ; Pastor, María Antonia ; Sangueza, Omar P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a325t-72f32f4dc8947568cc5591302a9ab210865e5c5f071fa3465ed9aa7100b9fe83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Antigens, CD - analysis</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Gene Deletion</topic><topic>Genes, Retinoblastoma - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulinopathies</topic><topic>Immunoglobulins - analysis</topic><topic>Immunohistochemistry</topic><topic>Immunopathology</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - chemistry</topic><topic>Multiple Myeloma - genetics</topic><topic>Multiple Myeloma - pathology</topic><topic>Plasma Cells - pathology</topic><topic>Skin - immunology</topic><topic>Skin - pathology</topic><topic>Skin Neoplasms - chemistry</topic><topic>Skin Neoplasms - genetics</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - secondary</topic><toplevel>online_resources</toplevel><creatorcontrib>Requena, Luis</creatorcontrib><creatorcontrib>Kutzner, Heinz</creatorcontrib><creatorcontrib>Palmedo, Gabriele</creatorcontrib><creatorcontrib>Calonje, Eduardo</creatorcontrib><creatorcontrib>Requena, Celia</creatorcontrib><creatorcontrib>Pérez, Gemma</creatorcontrib><creatorcontrib>Pastor, María Antonia</creatorcontrib><creatorcontrib>Sangueza, Omar P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of dermatology (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Requena, Luis</au><au>Kutzner, Heinz</au><au>Palmedo, Gabriele</au><au>Calonje, Eduardo</au><au>Requena, Celia</au><au>Pérez, Gemma</au><au>Pastor, María Antonia</au><au>Sangueza, Omar P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases</atitle><jtitle>Archives of dermatology (1960)</jtitle><addtitle>Arch Dermatol</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>139</volume><issue>4</issue><spage>475</spage><epage>486</epage><pages>475-486</pages><issn>0003-987X</issn><issn>2168-6068</issn><eissn>1538-3652</eissn><eissn>2168-6084</eissn><coden>ARDEAC</coden><abstract>BACKGROUND Specific cutaneous involvement in patients with multiple myeloma (MM) is very uncommon. It usually occurs in late stages of MM as a reflection of increased tumor cell burden. We studied 8 patients with cutaneous involvement of MM without underlying bony lesions and reviewed the literature on this rare dermatologic manifestation. DESIGN We were particularly interested in the clinical course of patients with MM and cutaneous metastases, including survival once metastases were detected and the possible influence of various forms of therapy. Our goal was also to identify the immunoglobulin and the light-chain type in these cases, with emphasis on any possible association between a particular immunoglobulin class and cutaneous involvement, as well as the histopathologic, immunohistochemical, and cytogenetic features of the neoplastic plasma cells involving the skin. SETTING University department of dermatology, university hospital, and private practice. PATIENTS Medical records and biopsy specimens from 8 patients with MM and specific cutaneous lesions were reviewed. RESULTS
Cutaneous lesions consisted of multiple erythematous or violaceous nodules or plaques with a wide anatomical distribution. Histopathologically, 2 different patterns were identified: nodular and diffuse interstitial. Neoplastic plasma cells showed atypical features, and in 1 case they displayed a spindle shape, giving a sarcomatoid appearance to the lesion. Immunohistochemical studies demonstrated that neoplastic plasma cells were strongly positive for CD79a, CD138, and epithelial membrane antigen, and variably positive for VS38c and CD43. In each case the immunoglobulin profile and the light-chain type expression of the neoplastic cells were the same as those identified in the serum of the patients: 5 cases were IgAλ; 2 cases were IgGκ; and 1 case was IgAκ. In cases 2, 3, and 4, polymerase chain reaction investigations revealed monoclonal rearrangement for IgH genes, whereas the investigations for human herpesvirus 8 and Epstein-Barr virus yielded negative results. Fluorescent in situ hybridization investigations in these 3 cases demonstrated that the cutaneous neoplastic plasma cells showed the deletion of the rb-1 (retinoblastoma) gene. Despite aggressive chemotherapy, all 8 patients died a few months after the development of cutaneous involvement.
CONCLUSIONS
In our series, there was a perfect correlation of immunoglobulin and light-chain type between the serum electrophoresis and the cutaneous plasma cells. Patients with MM showed a short survival once cutaneous metastases appeared independently of the therapy. The deletion the rb-1 gene may provide prognostically relevant information to identify a high-risk subset of patients with MM.
Arch Dermatol. 2003;139:475-486--></abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>12707095</pmid><doi>10.1001/archderm.139.4.475</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-987X |
ispartof | Archives of dermatology (1960), 2003-04, Vol.139 (4), p.475-486 |
issn | 0003-987X 2168-6068 1538-3652 2168-6084 |
language | eng |
recordid | cdi_proquest_miscellaneous_73230836 |
source | MEDLINE; American Medical Association Journals |
subjects | Aged Antigens, CD - analysis Biological and medical sciences Female Gene Deletion Genes, Retinoblastoma - genetics Hematologic and hematopoietic diseases Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunoglobulins - analysis Immunohistochemistry Immunopathology In Situ Hybridization, Fluorescence Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Multiple Myeloma - chemistry Multiple Myeloma - genetics Multiple Myeloma - pathology Plasma Cells - pathology Skin - immunology Skin - pathology Skin Neoplasms - chemistry Skin Neoplasms - genetics Skin Neoplasms - pathology Skin Neoplasms - secondary |
title | Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20Involvement%20in%20Multiple%20Myeloma:%20A%20Clinicopathologic,%20Immunohistochemical,%20and%20Cytogenetic%20Study%20of%208%20Cases&rft.jtitle=Archives%20of%20dermatology%20(1960)&rft.au=Requena,%20Luis&rft.date=2003-04-01&rft.volume=139&rft.issue=4&rft.spage=475&rft.epage=486&rft.pages=475-486&rft.issn=0003-987X&rft.eissn=1538-3652&rft.coden=ARDEAC&rft_id=info:doi/10.1001/archderm.139.4.475&rft_dat=%3Cproquest_cross%3E325981511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233129894&rft_id=info:pmid/12707095&rft_ama_id=479282&rfr_iscdi=true |